Reductions in Human Papillomavirus-Disease Resource Use and Costs with Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccination: The FUTURE Study Economic Evaluation
| Autor: | Insinga, Ralph P., Dasbach, Erik J., Allen, Shannon E., Carides, George W., Myers, Evan R. |
|---|---|
| Zdroj: | In Value in Health 2008 11(7):1022-1032 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect